Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The role of cardioprotection in cancer therapy cardiotoxicity: JACC: CardioOncology state-of-the-art review.JACC: CardioOncology. 2022; 4: 19-37
- Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: a systematic review & bayesian network meta-analysis.Eur J Cancer. 2022; 169: 82-92
- Indices of effect existence and significance in the bayesian framework.Front Psychol. 2019; 10: 2767
- Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines.JACC: Heart Failure. 2022;
- Hypertension and incident cardiovascular events following ibrutinib initiation.Blood. 2019; 134: 1919-1928